Streetbeat News

Revenues

SATX

SatixFy has entered into a $9 million agreement with MDA Space to develop software for digital payload systems in LEO satellite constellations. The deal includes $6 million for software delivery and $3 million for future licensing, with an additional $4 million option for data plane access.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:45 pm

GM

General Motors (GM) reported that in China, their new energy vehicles outsold internal combustion engine models during the third quarter. Additionally, GM's Cruise team is working on improving technology and cost structure.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:41 pm

GM

General Motors (GM) is actively working to make its electric vehicles (EVs) profitable on an EBIT basis. The company is conducting dealer outreach and training, with a focus on luxury customers who show stronger EV consideration.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:41 pm

SNOA

Sonoma Pharmaceuticals is expanding its agreement with a healthcare distributor to distribute its wound care products in Canada. This expansion could potentially increase Sonoma's market reach and revenue in the Canadian market.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:38 pm

CDZI

Cadiz's ATEC Water Systems has secured $1.6 million in new contracts for filtration systems targeting arsenic, iron, and manganese, with deliveries scheduled for 2025.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:36 pm

HTCR

HeartCore Enterprises, Inc. (NASDAQ:HTCR) is shifting from annual to multi-year contracts in its core software business to drive longer and increased sales. This strategic move aims to enhance customer retention and generate recurring revenue streams, supporting sustained profitability.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:34 pm

CELU

Celularity Inc. (NASDAQ:CELU) has provided a corporate update, highlighting the acquisition of Rebound, a placental-derived product, and its impact on their portfolio. The company reported sales of over $24 million for the first half of 2024 and expects combined net sales of $50M-$56M. Celularity is working to regain Nasdaq compliance and plans to submit FDA notifications for new products in 2025-2026.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:33 pm

GE

GE Aerospace reported strong Q3 2024 results with a 6% revenue growth, a 28% increase in orders, and a 25% rise in earnings. The company raised its earnings and cash guidance for the year, yet shares fell 4.91% premarket.

Portfolio Pulse from Akanksha Bakshi

October 22, 2024 | 12:30 pm

ABL

Abacus Life has announced preliminary Q3 total revenue between $26 million and $28 million, which is below the estimated $29.256 million.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:28 pm

ABL

Abacus Life, Inc. (NASDAQ: ABL) announced preliminary Q3 2024 results, expecting revenue between $26M-$28M, a 23-33% YoY growth. However, a non-cash increase in warrant liability is expected to result in a GAAP net loss of $6M-$6.75M. Adjusted EBITDA is projected to grow 30-48% YoY.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:27 pm